Laura Indolfi: Good news in the fight against pancreatic cancer
Laura Indolfi: Bones notícies en la lluita contra el càncer de pàncrees
Laura Indolfi is revolutionizing cancer treatment with new technologies including implantable devices for delivering drugs locally to the site of a tumor. Full bio
Double-click the English transcript below to play the video.
at least one person on the screen?
de les persones de la pantalla.
in their fields.
tots són molt coneguts en les seves àrees.
all of them have in common?
de càncer de pàncrees.
very sad this news,
realment dolenta,
darrere d'aquestes persones
of how lethal this disease can be.
de la mortalitat d'aquesta malaltia.
of cancer deaths,
amb més mortalitat,
will survive beyond five years.
sobreviuran cinc anys.
with breast cancer,
amb el càncer de pit,
is almost 90 percent.
és gairebé d'un 90%.
quan es diagnostica
with pancreatic cancer
assumim que és una sentència de mort.
certain death sentence.
is that in the last 40 years,
en els últims 40 anys
no ha canviat,
treatment more effective?
el tractament d'aquest càncer?
that seem impossible,
que semblen impossibles,
innovative solutions
with pancreatic cancer
of your belly, literally.
al mig del ventre.
al dibuix.
organs in front.
que es troben al davant.
by many other vital organs,
òrgans vitals
the bile duct.
el conducte biliar.
to grow into those organs
de créixer en aquests òrgans
el càncer de pàncrees
also prevents the doctor
impedeix que els metges
for breast cancer, for example.
amb el càncer de mama, per exemple.
chemotherapy as the only option
que la quimioteràpia és l'única opció
piece of bad news.
very few blood vessels.
gairebé no tenen vasos sanguinis.
about the blood vessel of a tumor?
els vasos sanguinis d'un tumor?
how chemotherapy works.
la quimioteràpia.
until it reaches the tumor site.
fins que arriba al tumor.
trying to reach a destination.
per arribar a un destí.
doesn't have an exit on the highway?
no tingués sortida a l'autopista?
el càncer de pàncrees.
throughout all of your body.
per tot el cos.
for the patients overall,
to have a whole-body treatment
és contraproduent tractar tot el cos
and effort have gone towards
i esforços per trobar
to treat pancreatic cancer,
per tractar el càncer,
in changing the way
el medicament al pacient.
good news, hopefully.
General Hospital in Boston,
a Boston,
the way we treat cancer
del càncer
drug delivery a reality.
en una realitat.
on top of your destination,
al lloc exacte on vols anar,
all around the highway.
into devices that look like this one.
en aparells com aquest.
that they can be folded
directly on top of the tumor
directament al tumor
that once they are positioned
fer de gàbia.
physically prevent the tumor
que el tumor vagi físicament
controlant així la metàstasi.
slowly and more effectively
de manera localitzada,
tractaments actuals.
whole-body treatment.
en estudis preclínics,
we have demonstrated
the response to treatment.
el resultat del tractament.
que ja coneixíem
where it's needed the most,
on més es necessita
12 vegades millor,
that is 12 times more powerful,
this technology to the next level.
aquesta tecnologia al següent nivell.
l'aprovació de la FDA
prior to asking the FDA for approval
will die from pancreatic cancer.
moriran de càncer de pàncrees.
allargar la vida dels pacients
extend their life
de subministrar el medicament,
more powerful and less toxic,
més poderós i menys tòxic,
to finding new innovative solutions
a noves solucions
semblen impossibles
ABOUT THE SPEAKER
Laura Indolfi - Biomedical entrepreneurLaura Indolfi is revolutionizing cancer treatment with new technologies including implantable devices for delivering drugs locally to the site of a tumor.
Why you should listen
Laura Indolfi is a biomedical entrepreneur, CEO and co-founder of PanTher Therapeutics, an early stage spin-out from MIT and MGH that provides superior technologies for revolutionizing the treatment of locally advanced inoperable solid tumors. Prior to this she served as an entrepreneur-in-residence at the MGH Cancer Center and as a research associate in the Harvard-MIT Institute for Medical Engineering and Science. She was selected as a TED Fellow in 2016.
Indolfi has broad professional experiences and interests ranging from biomedical engineering to entrepreneurship and outreaching initiative to promoting science. Her scientific expertise covers a broad range of therapeutic areas (cardio, cancer, inflammation, regenerative medicine) and approaches (drug delivery, cell therapy, implanted devices). Together with her strong technical background, Laura has hands-on business and managerial know-how developed during her biomedical business training at Sloan and Harvard Business Schools and with several consulting firms. She strongly believes in the power of outreach initiatives to promote research awareness and foster the public audience's discovery of the beauty of science. In 2014 the line of clothes Cytocouture, created in collaboration with Colombian designer Carlos Villamil and inspired by her cell-therapy research, won the global competition Descience.
Indolfi holds a MS/BS degree in materials science and engineering and a PhD in biomaterials from the University of Naples Federico II in Italy. Upon graduation, she joined the Harvard-MIT Division of health, science and technology, working on several projects spanning from devices for local drug delivery to tissue engineering approaches for cell therapies.
Laura Indolfi | Speaker | TED.com